Tilray (NASDAQ:TLRY) Issues Quarterly Earnings Results

Tilray (NASDAQ:TLRY) released its earnings results on Thursday. The company reported ($0.01) earnings per share for the quarter, topping the consensus estimate of ($0.04) by $0.03, Briefing.com reports. Tilray had a negative return on equity of 2.63% and a negative net margin of 30.26%. The firm had revenue of $200.00 million during the quarter, compared to analysts’ expectations of $218.70 million. During the same period in the prior year, the company earned ($0.10) earnings per share. The company’s quarterly revenue was up 13.0% on a year-over-year basis.

Tilray Price Performance

NASDAQ TLRY opened at $1.59 on Friday. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.42 and a current ratio of 2.27. Tilray has a fifty-two week low of $1.45 and a fifty-two week high of $2.97. The business has a fifty day moving average price of $1.76 and a two-hundred day moving average price of $1.86.

About Tilray

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.